Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) announced Thursday that elinzanetant, its experimental therapy for hot flashes, reached the ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

"Bayer is prioritising development of products ... performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the At the Veeva Commercial ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions ...

NOTE: Bayer's DIDGET™ Meter is only available to residents of the US, Croatia, Slovenia, UK and the Republic of Ireland. Key Features The only blood glucose meter that plugs into Nintendo DS or ...

Bayer Weedkiller Lawsuit Dismissed By Australian ... Breach In February Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates ...

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies ...

Orion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for the oral androgen ...

Together with an intimate group of health-care providers, women’s health advocates, and menopause experts, Montgomery and Dr. Yesmean Wahdan, vice president of medical affairs at Bayer Women’s ...